Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: Menopause. 2010 Nov–Dec;17(6):1152–1160. doi: 10.1097/gme.0b013e3181e102d9

Table 4.

Multivariable adjusted mean mammographic density by total vitamin D and calcium intake at baseline, stratified by category of percent density at baseline, Women's Health Initiative Mammogram Density Study (n = 808).

Percent Density (95% Confidence Interval) by Category of Percent Density
Nutrient < 1 % (n = 212) 1 - < 10% (n = 388) ≥ 10% (n = 208)
Total Vitamin D intake (IU/day)
    < 100 0.5 (0.4, 0.6) 3.7 (2.8, 4.6) 18.1 (14.4, 21.8)
    100 – 199 0.6 (0.4, 0.7) 4.5 (3.5, 5.6) 23.3 (20.2, 26.4)
    200 – 399 0.4 (0.2, 0.5) 3.7 (2.9, 4.4) 19.8 (16.0, 23.6)
    ≥ 400 0.5 (0.4, 0.6) 3.6 (2.7, 4.6) 16.9 (12.3, 21.5)
P = 0.16 P = 0.79 P = 0.67
Vitamin D from food sources (IU/day)
    < 100 0.5 (0.4, 0.6) 3.6 (2.9, 4.2) 17.0 (13.7, 20.3)
    100 – 150 0.5 (0.4, 0.6) 4.4 (3.5, 5.2) 20.0 (17.4, 22.7)
    150 – 199 0.5 (0.4, 0.6) 3.9 (3.0, 4.8) 22.6 (19.3, 25.9)
    ≥ 200 0.4 (0.3, 0.5) 3.7 (3.1, 4.3) 20.6 (17.1, 24.1)
P = 0.26 P = 0.50 P = 0.15
Vitamin D from supplements only
    No 0.5 (0.4, 0.6) 3.8 (3.0, 4.5) 22.4 (19.1, 25.7)
    Yes 0.5 (0.3, 0.6) 3.9 (3.1, 4.8) 17.1 (12.7, 21.4)
P = 0.72 P = 0.91 P = 0.09
Total calcium intake (mg/day)
    < 500 0.5 (0.4, 0.6) 3.4 (2.6, 4.3) 20.5 (16.5, 24.4)
    500 – 749 0.6 (0.5, 0.7) 4.2 (3.5, 5.0) 19.8 (16.0, 23.5)
    750 – 999 0.5 (0.4, 0.6) 4.0 (3.2, 4.9) 21.8 (18.2, 25.4)
    ≥ 1000 0.4 (0.4, 0.5) 3.6 (3.0, 4.2) 19.5 (16.8, 22.2)
P = 0.07 P = 0.66 P = 0.85
Calcium from food sources (mg/day)
    < 500 0.5 (0.4, 0.6) 4.0 (3.2, 4.9) 20.3 (16.7, 23.8)
    500 – 649 0.5 (0.4, 0.6) 4.2 (3.5, 4.9) 19.1 (15.0, 23.1)
    650 – 799 0.5 (0.3, 0.6) 3.1 (2.2, 4.0) 18.8 (15.2, 22.5)
    ≥ 800 0.5 (0.4, 0.6) 3.7 (3.2, 4.3) 21.6 (18.8, 24.4)
P = 0.93 P = 0.48 P = 0.27
Calcium from supplements
    None 0.6 (0.5, 0.7) 3.9 (3.3, 4.5) 21.1 (18.6, 23.6)
    < 500 0.4 (0.3, 0.5) 3.8 (3.0, 4.6) 20.2 (16.4, 24.1)
    ≥ 500 0.5 (0.3, 0.6) 3.7 (2.9, 4.6) 19.0 (16.0, 22.0)
P = 0.97 P = 0.48 P = 0.17

Adjusted for covariates in Model 1: age, race/ethnicity, body mass index, age at menarche, parity, oral contraceptive use and duration, previous HT use/duration, HT trial randomization assignment, family history of breast cancer, education, alcohol intake, smoking, total calorie intake, physical activity, Gail risk, and use of multivitamins.